BR0010563A - Composições isoladas de células da pele e métodos para seu uso - Google Patents

Composições isoladas de células da pele e métodos para seu uso

Info

Publication number
BR0010563A
BR0010563A BR0010563-5A BR0010563A BR0010563A BR 0010563 A BR0010563 A BR 0010563A BR 0010563 A BR0010563 A BR 0010563A BR 0010563 A BR0010563 A BR 0010563A
Authority
BR
Brazil
Prior art keywords
methods
skin cell
cell compositions
isolated skin
isolated
Prior art date
Application number
BR0010563-5A
Other languages
English (en)
Inventor
James D Watson
Lorna Strachan
Rene Onrust
Matthew Sleeman
Krishanand D Kumble
James G Murison
Original Assignee
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Res & Dev Corp Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of BR0010563A publication Critical patent/BR0010563A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

Patente de Invenção: "COMPOSIçõES ISOLADAS DE CéLULAS DA PELE E MéTODOS PARA SEU USO". Polinucleotídeos isolados que codificam polipeptídeos expressos em células da pele de mamíferos são proporcionados, junto com vetores de expressão e células hospedeiras compreendendo tais polinucleotídeos isolados. Métodos para o uso de tais polinucleotídeos e polipeptídeos também são proporcionados.
BR0010563-5A 1999-05-14 2000-05-15 Composições isoladas de células da pele e métodos para seu uso BR0010563A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/312,283 US6573095B1 (en) 1998-04-29 1999-05-14 Polynucleotides isolated from skin cells
PCT/NZ2000/000075 WO2000069884A2 (en) 1999-05-14 2000-05-15 Compositions isolated from skin cells and methods for their use

Publications (1)

Publication Number Publication Date
BR0010563A true BR0010563A (pt) 2002-02-19

Family

ID=23210737

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010563-5A BR0010563A (pt) 1999-05-14 2000-05-15 Composições isoladas de células da pele e métodos para seu uso

Country Status (10)

Country Link
US (1) US6573095B1 (pt)
EP (1) EP1185555A4 (pt)
JP (1) JP2002543824A (pt)
KR (1) KR20020013543A (pt)
CN (1) CN1373774A (pt)
AU (1) AU4958800A (pt)
BR (1) BR0010563A (pt)
CA (1) CA2374045A1 (pt)
NZ (1) NZ515388A (pt)
WO (1) WO2000069884A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6573095B1 (en) 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
US7294482B2 (en) * 1998-11-19 2007-11-13 Millennium Pharmaceuticals, Inc. EGF-like nucleic acids
EP2075335A3 (en) * 1998-12-22 2009-09-30 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
US20030009013A1 (en) * 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
JP2004502405A (ja) * 2000-01-25 2004-01-29 ハイセック，インコーポレーテッド トランスフォ−ミング成長因子アルファｔｇｆアルファ様ポリペプチドおよびポリヌクレオチドに関する方法と材料
AU2001260847A1 (en) * 2000-05-24 2001-12-03 Genesis Research And Development Corporation Limited Compositions isolated from skin cells and methods for their use
JP2004527210A (ja) 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー 内皮細胞発現パターンの評価法
WO2003087362A1 (fr) * 2002-04-03 2003-10-23 Banyu Pharmaceutical Co., Ltd. Nouveau gene recepteur couple a la proteine g et proteine bg8
EP1573034A4 (en) * 2002-06-20 2006-06-14 Bristol Myers Squibb Co IDENTIFICATION AND MODULATION OF A G-PROTEIN COUPLED RECEPTOR (GPCR) ASSOCIATED WITH COPD (CHRONIC-OBSTRUCTIVE LUNG DISEASE) AND NF-KB AND E-SELECTIN REGULATION, RAI3
US20040259163A1 (en) * 2002-06-21 2004-12-23 Zymogenetics, Inc. Antibodies to mammalian adhesion protease peptides
AU2003277583A1 (en) * 2002-11-06 2004-06-07 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Physiologically active polypeptide and its antibody and use thereof
US20050272067A1 (en) * 2004-03-10 2005-12-08 Macina Roberto A Compositions, splice variants and methods relating to cancer specific genes and proteins
JP2006137747A (ja) * 2004-10-14 2006-06-01 Hayashibara Biochem Lab Inc サイトカイン類及び／又はケモカイン類産生増強剤
WO2006069449A1 (en) * 2004-12-29 2006-07-06 The University Of British Columbia Chemokine receptor-independent immunomodulatory and anti-proliferative activity
CN109776656B (zh) * 2019-01-11 2022-03-11 广州领晟医疗科技有限公司 一种用于抑制血管新生的多肽tin7n及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
NZ332318A (en) 1996-03-19 2000-10-27 Human Genome Sciences Inc Chemokine alpha 2 and it's therapeutic and diagnostic use in treating illnesses
US5850020A (en) 1996-09-11 1998-12-15 Genesis Research & Development Corporation, Ltd. Materials and method for the modification of plant lignin content
AU6132698A (en) 1997-01-23 1998-08-18 Schering Corporation Mammalian chemokines; receptors; reagents; uses
DE19817557A1 (de) 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe
WO1999055865A1 (en) 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
US6573095B1 (en) 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
EP1131350A4 (en) 1998-11-19 2005-05-04 Millennium Pharm Inc NUCLEIC ACIDS AND POLYPEPTIDES AND CORRESPONDING USES THEREOF
GB9828840D0 (en) 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
AU6745700A (en) 1999-03-26 2000-11-02 Human Genome Sciences, Inc. 49 human secreted proteins
AU4468800A (en) 1999-04-20 2000-11-02 Zymogenetics Inc. Adipocyte complement related protein homolog zacrp3
WO2000073448A1 (en) 1999-05-27 2000-12-07 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp7
JP2003505083A (ja) 1999-07-21 2003-02-12 インサイト・ゲノミックス・インコーポレイテッド 受容体及び関連タンパク質
EP1218406A1 (en) 1999-08-11 2002-07-03 Curagen Corporation Nucleic acids and secreted polypeptides encoded thereby
US20040034192A1 (en) 2000-01-06 2004-02-19 Seishi Kato Human proteins having hyprophobic domains and dnas encoding these proteins

Also Published As

Publication number Publication date
EP1185555A2 (en) 2002-03-13
WO2000069884A3 (en) 2001-02-15
EP1185555A4 (en) 2004-05-19
US6573095B1 (en) 2003-06-03
CA2374045A1 (en) 2000-11-23
AU4958800A (en) 2000-12-05
CN1373774A (zh) 2002-10-09
NZ515388A (en) 2003-03-28
JP2002543824A (ja) 2002-12-24
WO2000069884A2 (en) 2000-11-23
KR20020013543A (ko) 2002-02-20

Similar Documents

Publication Publication Date Title
BR0010563A (pt) Composições isoladas de células da pele e métodos para seu uso
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
CY1109367T1 (el) Συνθεσεις και μεθοδοι για ενισχυση της παροχης θεραπευτικων παραγοντων σε κυτταρα
BRPI9811940A (pt) vetor de expressão para um polipeptídeo de ligação da interleucina-18 (il-18-bp), célula hospedeira procariótica transformada com o referido vetor, processo para produção de il-18-bp, proteína de fusão compreendendo o referido polipeptídeo, bem como il-18bp modificada.
ATE286907T1 (de) Cytokinin-designiertes lerk-5
BR9809816A (pt) Composições para cuidados pessoais contendo polìmeros enxertados enrijecidos.
NO950939L (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
BR9801652A (pt) Resorcinil-triazinas
DE69912870D1 (de) Kosmetische oder dermatologische Zusammensetzung, enthaltend zumindest ein natürliches oder rekombinantes Seidenprotein von Arachniden oder ein analoges Protein
BR9907189A (pt) Produtos da fração lipìdica do carotenóide de pepino do mar e métodos de uso
AR056723A2 (es) Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid
NO20052363L (no) Interferon-alfa polypeptider og konjugater
IT1291859B1 (it) Perfezionamento nei dispositivi di tenuta stagna per bottone di comando di strumenti, particolarmente per la corona di carica e di
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
WO2000029448A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
BR0009396A (pt) Lipase, composição detergente, sequência de dna, vetor de expressão, célula hospedeira transformada, e, processo para produzir a lipase
DK1144666T3 (da) Replikationsdeficient baculovirusekspressionssystem
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
BR0008035A (pt) Composições isoladas de células de planta e seu uso na modificação de sinalização de célula de planta
WO1996034965A3 (en) Chimeric mcp and daf proteins with cell surface localizing domain
GB2287941A (en) Human neuronal nicotinic acetylcholine receptor compositions and methods employing same

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]